Susceptibility Testing of Pseudomonas aeruginosa Isolates and Clinical Response to Parenteral Antibiotic Administration

This publication has 16 references indexed in Scilit:

• Effect of Chronic Intermittent Administration of Inhaled Tobramycin on Respiratory Microbial Flora in Patients with Cystic Fibrosis
  The Journal of Infectious Diseases, 1999
• Comparison of a β-lactam alone versus β-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis
  The Journal of Pediatrics, 1999
• Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
  New England Journal of Medicine, 1999
• Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis
  Pediatric Pulmonology, 1989
• Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo
  The Journal of Infectious Diseases, 1983
• Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?
  The Journal of Pediatrics, 1980
• Multiple Isolates of Pseudomonas aeruginosa with Differing Antimicrobial Susceptibility Patterns from Patients with Cystic Fibrosis
  The Journal of Infectious Diseases, 1979
• Penetration of Tobramycin into Infected Extravascular Fluids and Its Therapeutic Effectiveness
  The Journal of Infectious Diseases, 1977
• Pseudomonas Bacteremia: Pharmacologic and Other Bases for Failure of Treatment with Gentamicin
  The Journal of Infectious Diseases, 1971
• DEVELOPMENT OF STREPTOMYCIN RESISTANCE DURING TREATMENT
  JAMA, 1946